SOURCES SOUGHT
65 -- iCell Cardiomyocytes
- Notice Date
- 2/8/2013
- Notice Type
- Sources Sought
- NAICS
- 541711
— Research and Development in Biotechnology
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 3900 NCTR Road, HFT-320, Bldg 50 | Rm 421, Jefferson, Arkansas, 72079, United States
- ZIP Code
- 72079
- Solicitation Number
- FDA113788
- Archive Date
- 3/6/2013
- Point of Contact
- Janice Heard, Phone: 215-717-3093
- E-Mail Address
-
janice.heard@fda.hhs.gov
(janice.heard@fda.hhs.gov)
- Small Business Set-Aside
- Total Small Business
- Description
- THIS IS FOR MARKET RESEARCH PURPOSES ONLY: This Sources Sought notice is to determine the availability and capability of small businesses, under NAICS Code 541711 as an actual manufacturer for the requirement described below. The information being sought is for information and planning purposes only and shall not be construes as a commitment on the part of the Government to award a contract. The Government does not intend to pay for any information submitted as a result of this notice. Any response received will not be used as a proposal. The information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. After a review of the responses received, a solicitation may be published in FedBizOpps. However, responses to this notice will not be considered adequate responses to the solicitation. **THERE WILL BE NO QUESTIONS AND ANSWER PERIOD**No Phone calls will be accepted. Requirements: The U.S. Food and Drug Administration (FDA) is seeking a small business concerns capable of meeting the FDA's requirement for the iCell Cardiomyoctes.. The iCell® Cardiomyocytes must be highly purified human cardiomyocytes derived from iPS cells through proprietary differentiation and purification protocols. The cells must express monomeric red fluorescent protein (mRFP) and blasticidin resistance, both of which are under the control of the alpha-myosin heavy chain (Myh6) promoter that allows simultaneous cardiomyocyte purification and identification. The iCell Cardiomyocytes must be purified by Myh6. iCell Cardiomyocytes are a mixture of spontaneously electrically active atrial, nodal, and ventricular-like myocytes that possess typical electrophysiological characteristics and exhibit expected electrophysiological and biochemical responses upon exposure to exogenous agents. The cells are a reliable source of human cardiomyocytes suitable for use in targeted drug discovery, toxicity testing, and other life science research. Response Date: All information should be submitted via email and received by February 19, 2013, at 3:00 p.m. Eastern Time
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/NCTR/FDA113788/listing.html)
- Place of Performance
- Address: U.S. Food and Drug Administration, 3900 NCTR Road, Jefferson, Arkansas, 72079, United States
- Zip Code: 72079
- Zip Code: 72079
- Record
- SN02983541-W 20130210/130208235557-bb8fbadad3e8b28c03e9d7e52ba47d31 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |